Share This
Create Your Own Business Intelligence Website
 
Input the stock code or the company name     Search  

<00329.HK> - OCI International Holdings Limited

 
 Stock Screener:Alcoholic Drinks & Tobacco, Health Products, Medicine, Investments & Assets Management
CH BEIDAHUANG C.P. POKPHAND GUOCO GROUP LEE HING CNEWECON FUND LERTHAI GROUP COSMOPOL INT'L GD LAND SUN HING VISION ASIA STANDARD CHINA MERCHANTS HENGTEN NET CCT FORTIS CENTRALWEALTHGP CCIAM FUTURE EN NATURAL BEAUTY CHINA EB LTD TSINGTAO BREW GEMINI INV CHINA INV DEV STYLAND HOLD ASIA ORIENT EASY ONE FIN CHINA STRATEGIC SAN MIGUEL HK PAK FAH YEOW ALI HEALTH MASON GP HOLD RA SILK ROAD ARTA TECHFIN RIVERA (HOLD) AIDIGONG WH GROUP CHINA RES BEER PROSP INV HOLD UPBEST GROUP CORE ECON INV DT CAPITAL CHINA BEST PT INTL DEV FDG KINETIC CHINA MED&HCARE TONTINE WINES INNOVATIVE PHAR WANJIA GROUP CSFG COCOON HOLDINGS ORIENTAL EXPL TIANDA PHARMA SIHUAN PHARM NEW SILKROAD LANSEN PHARMA GRAND PHARMA TRAD CHI MED FW HOLDINGS PASHUN INT'L ENDURANCE RP HUA HAN HEALTH CHINA INV FUND PLANETREE INT'L SOUTH CHINA FIN HK CHINESE LTD SHK HK IND UNI-BIO GROUP SHOUCHENG TAI UNITED HOLD SHANDONG XINHUA C FIN INT INV UBA INVESTMENTS SHANGHAI GROWTH CKLIFE SCIENCES VALUE PARTNERS CH INTERNET INV DYNASTY WINES ASIA COAL SHENG YUAN HLDG EXTRAWELL PHAR CMS BAIYUNSHAN PH SILVER BASE WAI YUEN TONG ASIA RESOURCES GOLDSTONE INV GLOBAL M CAP ELEGANCEOPTICAL QIANHAI HEALTH HARBOUR DIGITAL BESUNYEN CHINA LNG SHUNTEN INTL C ANIMAL HEALTH ZHONGZHENG INTL LEE'S PHARM L'OCCITANE CST GROUP C SMARTERENERGY NT PHARMA LAMTEX HLDGS HENGAN INT'L G-RESOURCES ESSEX BIO-TECH CDB INT'L INV CSPC PHARMA SINOPHARM KINGWORLD ARTS OPTICAL WEALTHKING INV CMBC CAP-NEW YOUTH CHAMP CGN MINING SINO BIOPHARM HUIYIN HLDGS GP CHINA GEM HLDGS KAI YUAN HLDGS CH INNOVATION CH INV FIN GP NATIONAL INV PROSPER FUTURE FIRST CAP GP BAWANG GROUP PIONEER PHARM CHINA CINDA MAJOR HLDGS OCUMENSION-B PURAPHARM LIVZON PHARMA FRONTAGE 3SBIO HEC PHARM SHEUNG YUE GP MODERN CHI MED FUSEN PHARM TONG REN TANG CONSUN PHARMA SDITC CIRC ESR REALWAY CAPITAL BUD APAC SANAI HEALTH GP CR HOLDINGS SSY GROUP REAL NUTRI AUSUPREME SIMCERE PHARMA JBM HEALTHCARE LUYE PHARMA FOSUN PHARMA UNI HEALTH HUARONG INV CHARMACY PHAR CH FIN LEASING CAPITAL VC DAWNRAYS PHARMA WUXI APPTEC HUA MEDICINE-B SH PHARMA JACOBSON PHARMA CHINA HUARONG TRACKER FUND ISHARES A50 HSCEI ETF HS HSI ETF SHINEWAY PHARM LONGRUN TEA CHINARES PHARMA VINDA INT'L SINOLIFE UTD TYCOON GROUP TONGRENTANGCM HANSOH PHARMA ZHONGZHIPHARM PHARMARON MING FAI INT'L TOWN HEALTH UNITED LAB CTIHK NEW RAY MEDIC JOINN JD HEALTH ZHAOKE OPHTH-B ASYMCHEM SINCO PHARMA TEMPUS HOLD HINSANG GROUP GOLDEN THROAT CHI ENGY HOLD HAO WEN HLDGS ACR HOLDINGS CB GLOBAL CH BIOTECH SER JILIN CHANGLONG MADISON HLDG 8088 INVESTMENT CHINESE STRAT C FORTUNE INV CH DEMETER FIN GF HEALTHCARE GRACEWINE FARNOVA GROUP CRMI CHINA ECO-FARM PALINDA GROUP COMBEST HOLD BAYTACARE PHARM GT STEEL W2308 C HEALTH GP SILK RD ENERGY MINGWAH HI TECH NEP INTERLONG LARRY JEWELRY TREE HOLDINGS WINE'S LINK TRUE PARTNER
 
 Basic Datum
Company name Lot P/E P/B EPS DPS
OCI INTL 4000 -182.84 9.362 -0.0169 0.0
Profile Information Data Financial Ratios Profit Loss Cash Flow Balance Earnings Dividend
 
 
 
 Company Rating
Date Broker Company name Rating Target
≫More
 
 Company performance - Published
Date Company name Turnover* Profit* % Dividend
≫More
 
 
 
 Top Gain / Loss Show All Charts 
 
 Value
Name Updated Value Change Change %
HSI 01-19 15:47 24048.6  64.17  0.27%
OCI INTL 01-05 09:53 3.18  0.02  0.63%
≫More
 
 Expert Commentary
2021-12-29 金龍指數連跌4日,除左關注內地疫情,螞蟻集團旗下一直受監管機構關注慨網上醫保互助平台「相互寶」宣布下月底停止運作。受消息影響,除美國股價噚晚要跌,阿里巴巴(09988)及京東集團(09618)港股今朝亦受壓。另一方面,科指依家距離面世以黎低位只差約2%,後市係咪會繼續尋底? 艾德證券期貨投資策略總監文錦輝指,睇到科指仍有壓力,係年底前要走慨投資者都走左,科指畀人掟到呢個位,再跌落去都冇意思,中資科技股業務冇變,只係監管加辣,除左阿里系外,其餘大部分科技股只要符合監管要求,加上內地經濟唔係一下子急挫,相信明年投資呢些跌倒咁殘慨科技股冇壞,不過,如果市盈率(PE)太貴就唔好入手。
 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2022Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.